FIELD: medicine. SUBSTANCE: method involves carrying out laser stimulation of reflexogenic zones in nasal mucosa using 0.89 mcm wavelength and 1500-3000 Hz frequency radiation during 256 s daily to each nostril. EFFECT: enhanced effectiveness of treatment; low risk of traumatic injuries.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF CEREBRAL ANGIODYSTONIA | 1997 |
|
RU2149043C1 |
| METHOD FOR APPLYING LASER RADIATION THERAPY IN TREATING THE CASES OF PHARMACORESISTANT DEPRESSIVE DISORDERS | 2003 |
|
RU2243010C1 |
| METHOD OF LOW-INTENSIVE LASER THERAPY OF NEUROTIC DISORDERS | 2009 |
|
RU2440161C2 |
| METHOD FOR TREATING THE CASES OF NEURODERMATITIS | 2004 |
|
RU2269347C1 |
| METHOD OF TREATMENT OF LOCOMOTOR SYSTEM DISEASE | 1995 |
|
RU2104070C1 |
| METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1994 |
|
RU2114653C1 |
| METHOD FOR PREDICTING SCHIZOPHRENIA EXACERBATION | 1995 |
|
RU2120637C1 |
| METHOD OF TREATING PATHOLOGIC PSYCHIC STATES | 2010 |
|
RU2423098C1 |
| LASER THERAPY METHOD FOR TREATING THE CASES OF CRANIOCEREBRAL INJURIES AGGRAVATED WITH CRANIUM BASE FRACTURE | 2002 |
|
RU2207173C1 |
| METHOD OF TREATING PSYCOPHARMACOTHERAPY-RESISTANT SCHIZOPHRENIA | 2009 |
|
RU2412720C1 |
